380 related articles for article (PubMed ID: 30036759)
1. Neurofilament relates to white matter microstructure in older adults.
Moore EE; Hohman TJ; Badami FS; Pechman KR; Osborn KE; Acosta LMY; Bell SP; Babicz MA; Gifford KA; Anderson AW; Goldstein LE; Blennow K; Zetterberg H; Jefferson AL
Neurobiol Aging; 2018 Oct; 70():233-241. PubMed ID: 30036759
[TBL] [Abstract][Full Text] [Related]
2. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid biomarkers of neurofibrillary tangles and synaptic dysfunction are associated with longitudinal decline in white matter connectivity: A multi-resolution graph analysis.
Kim WH; Racine AM; Adluru N; Hwang SJ; Blennow K; Zetterberg H; Carlsson CM; Asthana S; Koscik RL; Johnson SC; Bendlin BB; Singh V
Neuroimage Clin; 2019; 21():101586. PubMed ID: 30502079
[TBL] [Abstract][Full Text] [Related]
4. Axonal Injury Partially Mediates Associations Between Increased Left Ventricular Mass Index and White Matter Damage.
Moore EE; Khan OA; Shashikumar N; Pechman KR; Liu D; Bell SP; Nair S; Terry JG; Gifford KA; Anderson AW; Landman BA; Blennow K; Zetterberg H; Hohman TJ; Carr JJ; Jefferson AL
Stroke; 2022 Mar; 53(3):808-816. PubMed ID: 34702069
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal Fluid 7-Ketocholesterol Level is Associated with Amyloid-β42 and White Matter Microstructure in Cognitively Healthy Adults.
Iriondo A; García-Sebastian M; Arrospide A; Arriba M; Aurtenetxe S; Barandiaran M; Clerigue M; Ecay-Torres M; Estanga A; Gabilondo A; Izagirre A; Saldias J; Tainta M; Villanua J; Blennow K; Zetterberg H; Mar J; Abad-García B; Dias IHK; Goñi FM; Martínez-Lage P
J Alzheimers Dis; 2020; 76(2):643-656. PubMed ID: 32538843
[TBL] [Abstract][Full Text] [Related]
6. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
[TBL] [Abstract][Full Text] [Related]
7. Plasma neurofilament light levels correlate with white matter damage prior to Alzheimer's disease: results from ADNI.
Nabizadeh F; Balabandian M; Rostami MR; Kankam SB; Ranjbaran F; Pourhamzeh M;
Aging Clin Exp Res; 2022 Oct; 34(10):2363-2372. PubMed ID: 35226303
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid β-amyloid
Osborn KE; Liu D; Samuels LR; Moore EE; Cambronero FE; Acosta LMY; Bell SP; Babicz MA; Gordon EA; Pechman KR; Davis LT; Gifford KA; Hohman TJ; Blennow K; Zetterberg H; Jefferson AL
Neurobiol Aging; 2018 Aug; 68():18-25. PubMed ID: 29702372
[TBL] [Abstract][Full Text] [Related]
9. Relationships Between Diffusion Tensor Imaging and Cerebrospinal Fluid Metrics in Early Stages of the Alzheimer's Disease Continuum.
Alm KH; Bakker A
J Alzheimers Dis; 2019; 70(4):965-981. PubMed ID: 31306117
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease.
Melah KE; Lu SY; Hoscheidt SM; Alexander AL; Adluru N; Destiche DJ; Carlsson CM; Zetterberg H; Blennow K; Okonkwo OC; Gleason CE; Dowling NM; Bratzke LC; Rowley HA; Sager MA; Asthana S; Johnson SC; Bendlin BB
J Alzheimers Dis; 2016; 50(3):873-86. PubMed ID: 26836182
[TBL] [Abstract][Full Text] [Related]
11. Association of Cerebrospinal Fluid Neurofilament Light Protein With Risk of Mild Cognitive Impairment Among Individuals Without Cognitive Impairment.
Kern S; Syrjanen JA; Blennow K; Zetterberg H; Skoog I; Waern M; Hagen CE; van Harten AC; Knopman DS; Jack CR; Petersen RC; Mielke MM
JAMA Neurol; 2019 Feb; 76(2):187-193. PubMed ID: 30419087
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage.
Meeker KL; Butt OH; Gordon BA; Fagan AM; Schindler SE; Morris JC; Benzinger TLS; Ances BM
Neurobiol Dis; 2022 May; 166():105662. PubMed ID: 35167933
[TBL] [Abstract][Full Text] [Related]
13. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.
Olsson B; Portelius E; Cullen NC; Sandelius Å; Zetterberg H; Andreasson U; Höglund K; Irwin DJ; Grossman M; Weintraub D; Chen-Plotkin A; Wolk D; McCluskey L; Elman L; Shaw LM; Toledo JB; McBride J; Hernandez-Con P; Lee VM; Trojanowski JQ; Blennow K
JAMA Neurol; 2019 Mar; 76(3):318-325. PubMed ID: 30508027
[TBL] [Abstract][Full Text] [Related]
14. Neurofilament protein in cerebrospinal fluid: a marker of white matter changes.
Sjögren M; Blomberg M; Jonsson M; Wahlund LO; Edman A; Lind K; Rosengren L; Blennow K; Wallin A
J Neurosci Res; 2001 Nov; 66(3):510-6. PubMed ID: 11746370
[TBL] [Abstract][Full Text] [Related]
15. CSF T-Tau/Aβ42 predicts white matter microstructure in healthy adults at risk for Alzheimer's disease.
Bendlin BB; Carlsson CM; Johnson SC; Zetterberg H; Blennow K; Willette AA; Okonkwo OC; Sodhi A; Ries ML; Birdsill AC; Alexander AL; Rowley HA; Puglielli L; Asthana S; Sager MA
PLoS One; 2012; 7(6):e37720. PubMed ID: 22701578
[TBL] [Abstract][Full Text] [Related]
16. Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression.
Zetterberg H; Skillbäck T; Mattsson N; Trojanowski JQ; Portelius E; Shaw LM; Weiner MW; Blennow K;
JAMA Neurol; 2016 Jan; 73(1):60-7. PubMed ID: 26524180
[TBL] [Abstract][Full Text] [Related]
17. Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease.
Schultz SA; Strain JF; Adedokun A; Wang Q; Preische O; Kuhle J; Flores S; Keefe S; Dincer A; Ances BM; Berman SB; Brickman AM; Cash DM; Chhatwal J; Cruchaga C; Ewers M; Fox NN; Ghetti B; Goate A; Graff-Radford NR; Hassenstab JJ; Hornbeck R; Jack C; Johnson K; Joseph-Mathurin N; Karch CM; Koeppe RA; Lee AKW; Levin J; Masters C; McDade E; Perrin RJ; Rowe CC; Salloway S; Saykin AJ; Sperling R; Su Y; Villemagne VL; Vöglein J; Weiner M; Xiong C; Fagan AM; Morris JC; Bateman RJ; Benzinger TLS; Jucker M; Gordon BA;
Neurobiol Dis; 2020 Aug; 142():104960. PubMed ID: 32522711
[TBL] [Abstract][Full Text] [Related]
18. Lower Left Ventricular Ejection Fraction Relates to Cerebrospinal Fluid Biomarker Evidence of Neurodegeneration in Older Adults.
Kresge HA; Liu D; Gupta DK; Moore EE; Osborn KE; Acosta LMY; Bell SP; Pechman KR; Gifford KA; Mendes LA; Wang TJ; Blennow K; Zetterberg H; Hohman TJ; Jefferson AL
J Alzheimers Dis; 2020; 74(3):965-974. PubMed ID: 32144980
[TBL] [Abstract][Full Text] [Related]
19. Subtle Differences in Cognition in 70-Year-Olds with Elevated Cerebrospinal Fluid Neurofilament Light and Neurogranin: A H70 Cross-Sectional Study.
Rådestig MA; Skoog J; Zetterberg H; Skillbäck T; Zettergren A; Sterner TR; Fässberg MM; Sacuiu S; Waern M; Wetterberg H; Blennow K; Skoog I; Kern S
J Alzheimers Dis; 2023; 91(1):291-303. PubMed ID: 36617786
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer's disease.
Lista S; Toschi N; Baldacci F; Zetterberg H; Blennow K; Kilimann I; Teipel SJ; Cavedo E; Dos Santos AM; Epelbaum S; Lamari F; Dubois B; Floris R; Garaci F; Hampel H;
Neurochem Int; 2017 Sep; 108():355-360. PubMed ID: 28527630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
